John W. Kozarich, Director at LIGAND PHARMACEUTICALS INC (LGND), sold 913 shares at $186.59 ($173K) on 2026-01-02, disclosed to the SEC on 2026-01-06.
Open-market sale of $173k LGND by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $186.59 | 21 | $4K | 2.3% |
| 2 | $187.95 | 91 | $17K | 9.9% |
| 3 | $187.95 | 91 | $17K | 9.9% |
| 4 | $188.96 | 102 | $19K | 11.1% |
| 5 | $188.96 | 102 | $19K | 11.1% |
| 6 | $190.27 | 207 |
| $39K |
| 22.7% |
| 7 | $190.27 | 207 | $39K | 22.7% |
| 8 | $192.40 | 46 | $9K | 5.1% |
| 9 | $192.40 | 46 | $9K | 5.1% |
| Total | $189.65 avg | 913 | $173K | 100% |
| Filing → |
| LGND | SELL | 2026-03-04 | $179K | — | Filing → |
| LGND | SELL | 2026-02-04 | $175K | — | Filing → |
| LGND | SELL | 2025-12-03 | $91K | — | Filing → |